Fullscope-seq: Spatial Transcriptomics for Drug Target Discovery

Researchers have developed Fullscope-seq, a spatial transcriptomics method combining Stereo-seq with long-read sequencing to map full-length RNA transcripts and alternative splicing patterns at single-cell resolution within intact macaque brain tissue, according to a study published in Nature Methods.

How Fullscope-seq Works in Macaque Brain Tissue

Traditional spatial transcriptomics approaches measure where genes are active, but they often collapse distinct messenger RNA variants into a single measurement. Fullscope-seq solves this limitation by pairing Stereo-seq, which provides high-resolution spatial mapping across large tissue sections, with long-read sequencing technologies that read complete RNA molecules. When researchers applied this method to macaque brain tissue, they captured the exact spatial location of full-length RNA transcripts at single-cell resolution. According to the study findings, the technique identified thousands of transcript isoforms that varied across cortical layers, specific brain regions, and individual cell types, exposing a previously unrecognized layer of spatial complexity in gene regulation.

Did You Know?

While standard transcriptomics treats each gene as a single entity, individual genes frequently generate multiple RNA isoforms through alternative splicing. These distinct versions can produce proteins with opposing biological functions.

Why Transcript Isoforms Matter for Drug Discovery

Alternative splicing produces diverse messenger RNA transcripts from a single gene, meaning different variants within the same cell can either promote disease or protect against it. Because conventional platforms overlook these distinctions, drug developers often target an entire gene rather than precise molecular variants. By mapping which specific transcript isoforms reside in exact anatomical regions and cell populations, Fullscope-seq helps researchers identify disease-associated isoforms that were previously hidden. According to study data, this approach improves target validation by distinguishing functional variants, uncovers spatial biomarkers linked to disease progression, and explains why specific therapies succeed in some cell populations while failing in others.

Expanding Molecular Resolution in Spatial Omics

Over the past five years, spatial biology platforms like Stereo-seq, MERFISH, and Visium have advanced rapidly to map gene expression within intact tissues. However, most established platforms generate gene-level data rather than isoform-level details. Fullscope-seq aligns with a broader industry shift toward increasing molecular resolution in spatial omics. Recent technological innovations have extended spatial mapping beyond RNA to incorporate proteins, chromatin accessibility, and multiomic datasets. Meanwhile, advanced computational tools now allow researchers to integrate these complex layers of information, shifting the focus of spatial biology from simple tissue mapping toward uncovering direct mechanisms of disease.

Future Challenges for Spatial Isoform Mapping

Translating spatial isoform mapping into clinical applications requires overcoming several developmental hurdles. Like many emerging omics technologies, Fullscope-seq must demonstrate broad scalability before widespread clinical adoption. Future research will focus on applying the method directly to human disease tissues, integrating isoform data with spatial proteomics and epigenomics, improving overall throughput, and reducing sequencing costs. Additionally, developers aim to incorporate advanced artificial intelligence tools capable of interpreting increasingly complex spatial datasets. The ultimate challenge will involve determining how spatial isoform data translates into actionable clinical targets and reliable biomarkers for oncology, neurodegeneration, and rare genetic disorders.

Frequently Asked Questions

What is Fullscope-seq?

Fullscope-seq is a spatial transcriptomics technology that combines Stereo-seq with long-read sequencing to capture full-length RNA transcripts and alternative splicing patterns at single-cell resolution within intact tissues.

Why are transcript isoforms important in disease biology?

A single gene can produce multiple RNA isoforms through alternative splicing, yielding proteins with different or even opposing functions. Some variants promote disease while others remain protective, making isoform-level data critical for targeted drug discovery.

What tissue was used to demonstrate Fullscope-seq?

Researchers demonstrated the Fullscope-seq technique using macaque brain tissue, successfully identifying thousands of transcript isoforms across different cortical layers and cell types.

How does this technology assist drug developers?

It helps identify hidden disease-associated isoforms, improves target validation, and discovers spatial biomarkers linked to disease progression by revealing precisely which version of a gene is active and where.